PRESENTATION · Dec 2024 · PDF
Science
Explore conditions, clinical trials, and the latest research.
These pages contain non-exhaustive scientific information about uses of products that have not yet been approved by regulatory authorities, as their efficacy and safety for these uses have not yet been established. The information is provided for educational and scientific exchange purposes, and does not suggest products should be used in a manner not consistent with their respective label approved by the regulatory authorities, which may differ by geography. Any publication reflects the state of knowledge at the time it was published. The information is not medical advice and cannot replace the independent medical judgement of a healthcare professional.
PRESENTATION · Dec 2024 · PDF
BBP-418 - MDA 2024 - FORTIFY Phase 3 Trial Design
PRESENTATION · Dec 2024 · PDF
Acoramidis - AHA 2024 - Relationship between CVH and survival in the acoramidis-treated participants within ATTRibute-CM
PRESENTATION · Dec 2024 · PDF
ADH1 - ENDO 2024 Characteristics of Adults with ADH1 enrolled in CLARIFY
PRESENTATION · Dec 2024 · PDF
BBP-418 - MDA 2024 - FORTIFY Phase 3 Trial Design
PRESENTATION · Dec 2024 · PDF
Acoramidis - HFSA 2024 - ATTRibute-CM Post Hoc Recurrent Event Analyses
PRESENTATION · Dec 2024 · PDF